| 000 | 02627 a2200793 4500 | ||
|---|---|---|---|
| 005 | 20250517140920.0 | ||
| 264 | 0 | _c20170807 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2016.12.039 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCao, Su-Mei | |
| 245 | 0 | 0 |
_aNeoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c04 2017 |
||
| 300 |
_a14-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAftercare |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma _xtherapy |
| 650 | 0 | 4 |
_aChemoradiotherapy _xadverse effects |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xmethods |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNasopharyngeal Carcinoma |
| 650 | 0 | 4 |
_aNasopharyngeal Neoplasms _xtherapy |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aYang, Qi | |
| 700 | 1 | _aGuo, Ling | |
| 700 | 1 | _aMai, Hai-Qiang | |
| 700 | 1 | _aMo, Hao-Yuan | |
| 700 | 1 | _aCao, Ka-Jia | |
| 700 | 1 | _aQian, Chao-Nan | |
| 700 | 1 | _aZhao, Chong | |
| 700 | 1 | _aXiang, Yan-Qun | |
| 700 | 1 | _aZhang, Xiu-Ping | |
| 700 | 1 | _aLin, Zhi-Xiong | |
| 700 | 1 | _aLi, Wei-Xiong | |
| 700 | 1 | _aLiu, Qing | |
| 700 | 1 | _aQiu, Fang | |
| 700 | 1 | _aSun, Rui | |
| 700 | 1 | _aChen, Qiu-Yan | |
| 700 | 1 | _aHuang, Pei-Yu | |
| 700 | 1 | _aLuo, Dong-Hua | |
| 700 | 1 | _aHua, Yi-Jun | |
| 700 | 1 | _aWu, Yi-Shan | |
| 700 | 1 | _aLv, Xing | |
| 700 | 1 | _aWang, Lin | |
| 700 | 1 | _aXia, Wei-Xiong | |
| 700 | 1 | _aTang, Lin-Quan | |
| 700 | 1 | _aYe, Yan-Fang | |
| 700 | 1 | _aChen, Ming-Yuan | |
| 700 | 1 | _aGuo, Xiang | |
| 700 | 1 | _aHong, Ming-Huang | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 75 _gp. 14-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2016.12.039 _zAvailable from publisher's website |
| 999 |
_c26893591 _d26893591 |
||